Deborah E. Pascoe
Nessuna posizione attualmente
Profilo
Deborah E.
Pascoe is the founder of Flora Therapeutics, Inc. (founded in 2015).
She previously worked as an Operations Director at 23andMe, Inc., a Principal at Genentech, Inc. and Scios, Inc., and as a Visiting Scientist at Merck & Co., Inc. Pascoe holds a doctorate from Northwestern University and an undergraduate degree from The University of Queensland.
Precedenti posizioni note di Deborah E. Pascoe
| Società | Posizione | Fine |
|---|---|---|
Flora Therapeutics, Inc.
 Flora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flora Therapeutics, Inc. develops targeted microbial therapeutics based on comprehensive human microbiome data. The company was founded by Deborah Pascoe on July 22, 2015 and is headquartered in San Francisco, CA. | Fondatore | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Corporate Officer/Principal | - |
23andMe, Inc.
 23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Corporate Officer/Principal | - |
Formazione di Deborah E. Pascoe
| Northwestern University | Doctorate Degree |
| The University of Queensland | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Aziende private | 4 |
|---|---|
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
Flora Therapeutics, Inc.
Flora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flora Therapeutics, Inc. develops targeted microbial therapeutics based on comprehensive human microbiome data. The company was founded by Deborah Pascoe on July 22, 2015 and is headquartered in San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Deborah E. Pascoe
